BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsang JS, Dobaño C, VanDamme P, Moncunill G, Marchant A, Othman RB, Sadarangani M, Koff WC, Kollmann TR. Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome? Trends Immunol 2020;41:457-65. [PMID: 32340868 DOI: 10.1016/j.it.2020.04.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Karachaliou M, Moncunill G, Espinosa A, Castaño-vinyals G, Rubio R, Vidal M, Jiménez A, Prados E, Carreras A, Cortés B, Blay N, Bañuls M, Pleguezuelos V, Melero NR, Serra P, Parras D, Izquierdo L, Santamaría P, Carolis C, Papantoniou K, Goldberg X, Aguilar R, Garcia-aymerich J, de Cid R, Kogevinas M, Dobaño C. SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia. BMC Med 2022;20. [DOI: 10.1186/s12916-022-02547-2] [Reference Citation Analysis]
2 George PJ, Marches R, Nehar-belaid D, Banchereau J, Lustigman S. The Th1/Tfh-like biased responses elicited by the rASP-1 innate adjuvant are dependent on TRIF and Type I IFN receptor pathways. Front Immunol 2022;13:961094. [DOI: 10.3389/fimmu.2022.961094] [Reference Citation Analysis]
3 Lipsit S, Facciuolo A, Scruten E, Wilkinson J, Plastow G, Kusalik A, Napper S. Signaling differences in peripheral blood mononuclear cells of high and low vaccine responders prior to, and following, vaccination in piglets. Vaccine X 2022;11:100167. [PMID: 35692279 DOI: 10.1016/j.jvacx.2022.100167] [Reference Citation Analysis]
4 Isgrò MA, Trillò G, Russo L, Tornesello AL, Buonaguro L, Tornesello ML, Miscio L, Normanno N, Bianchi AAM, Buonaguro FM, Cavalcanti E; anti-COVID-19 INT Task Force. Bimodal antibody-titer decline following BNT162b2 mRNA anti-SARS-CoV-2 vaccination in healthcare workers of the INT - IRCCS "Fondazione Pascale" Cancer Center (Naples, Italy). Infect Agent Cancer 2022;17:40. [PMID: 35902961 DOI: 10.1186/s13027-022-00451-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Tomalka JA, Suthar MS, Diamond MS, Sekaly RP. Innate antiviral immunity: how prior exposures can guide future responses. Trends Immunol 2022:S1471-4906(22)00138-7. [PMID: 35907675 DOI: 10.1016/j.it.2022.07.001] [Reference Citation Analysis]
6 Qin R, Meng G, Pushalkar S, Carlock MA, Ross TM, Vogel C, Mahal LK. Prevaccination Glycan Markers of Response to an Influenza Vaccine Implicate the Complement Pathway. J Proteome Res 2022. [PMID: 35757850 DOI: 10.1021/acs.jproteome.2c00251] [Reference Citation Analysis]
7 Wu S, Ross TM, Carlock MA, Ghedin E, Choi H, Vogel C. Evaluation of determinants of the serological response to the quadrivalent split-inactivated influenza vaccine. Mol Syst Biol 2022;18:e10724. [PMID: 35514207 DOI: 10.15252/msb.202110724] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hoff NA, Bratcher A, Kelly JD, Musene K, Kompany JP, Kabamba M, Mbala-Kingebeni P, Dighero-Kemp B, Kocher G, Elliott E, Reilly C, Halbrook M, Ilunga Kebela B, Gadoth A, Ngoie Mwamba G, Tambu M, McIlwain DR, Mukadi P, Hensley LE, Ahuka-Mundeke S, Rutherford GW, Muyembe-Tamfum JJ, Rimoin AW. Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccination in exposed and potentially exposed persons in the Democratic Republic of the Congo. Proc Natl Acad Sci U S A 2022;119:e2118895119. [PMID: 35110410 DOI: 10.1073/pnas.2118895119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Carlow DA, Lai JCY, Kollmann TR, Sadarangani M, Dutz JP. Cutaneous CpG adjuvant conditioning to enhance vaccine responses. Vaccine 2022:S0264-410X(21)01668-6. [PMID: 35144848 DOI: 10.1016/j.vaccine.2021.12.060] [Reference Citation Analysis]
10 Kim EY, Che Y, Dean HJ, Lorenzo-Redondo R, Stewart M, Keller CK, Whorf D, Mills D, Dulin NN, Kim T, Votoupal M, Walter M, Fernandez-Sesma A, Kim H, Wolinsky SM. Transcriptome-wide changes in gene expression, splicing, and lncRNAs in response to a live attenuated dengue virus vaccine. Cell Rep 2022;38:110341. [PMID: 35139383 DOI: 10.1016/j.celrep.2022.110341] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Moncunill G, Carnes J, Chad Young W, Carpp L, De Rosa S, Campo JJ, Nhabomba A, Mpina M, Jairoce C, Finak G, Haas P, Muriel C, Van P, Sanz H, Dutta S, Mordmüller B, Agnandji ST, Díez-padrisa N, Williams NA, Aponte JJ, Valim C, Neafsey DE, Daubenberger C, Mcelrath MJ, Dobaño C, Stuart K, Gottardo R. Transcriptional correlates of malaria in RTS,S/AS01-vaccinated African children: a matched case–control study. eLife 2022;11:e70393. [DOI: 10.7554/elife.70393] [Reference Citation Analysis]
12 Lin K, Zhou Y, Ai J, Wang YA, Zhang S, Qiu C, Lian C, Gao B, Liu T, Wang H, Zhang H, Zhang Y, Fu Z, Li D, Jiang N, Guo J, Wu J, Wang YO, Song S, Li Q, Yin Y, Xia J, Xu Y, Yeap LS, Zheng X, Gu Y, Liu H, Zhang W, Meng FL. B cell Receptor Signatures Associating with Strong and Poor SARS-CoV-2 Vaccine Response. Emerg Microbes Infect 2022;:1-43. [PMID: 35045787 DOI: 10.1080/22221751.2022.2030197] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Coughlan L. Caught in a trap: How pre-clinical studies in laboratory mice exaggerate vaccine responses. Cell Rep Med 2021;2:100484. [PMID: 35028623 DOI: 10.1016/j.xcrm.2021.100484] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Aevermann BD, Shannon CP, Novotny M, Ben-Othman R, Cai B, Zhang Y, Ye JC, Kobor MS, Gladish N, Lee AH, Blimkie TM, Hancock RE, Llibre A, Duffy D, Koff WC, Sadarangani M, Tebbutt SJ, Kollmann TR, Scheuermann RH. Machine Learning-Based Single Cell and Integrative Analysis Reveals That Baseline mDC Predisposition Correlates With Hepatitis B Vaccine Antibody Response. Front Immunol 2021;12:690470. [PMID: 34777332 DOI: 10.3389/fimmu.2021.690470] [Reference Citation Analysis]
15 Massa F, Cremoni M, Gérard A, Grabsi H, Rogier L, Blois M, Couzin C, Hassen NB, Rouleau M, Barbosa S, Martinuzzi E, Fayada J, Bernard G, Favre G, Hofman P, Esnault VLM, Czerkinsky C, Seitz-Polski B, Glaichenhaus N, Sicard A. Safety and cross-variant immunogenicity of a three-dose COVID-19 mRNA vaccine regimen in kidney transplant recipients. EBioMedicine 2021;73:103679. [PMID: 34763205 DOI: 10.1016/j.ebiom.2021.103679] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Mehrotra A, Bhushan B, Kumar A, Panigrahi M, Chauhan A, Kumari S, Saini BL, Dutt T, Mishra BP. Characterisation and comparison of immune response mechanisms in an indigenous and a commercial pig breed after classical swine fever vaccination. Anim Genet 2021. [PMID: 34729794 DOI: 10.1111/age.13152] [Reference Citation Analysis]
17 Hou J, Wang S, Li D, Carpp LN, Zhang T, Liu Y, Jia M, Peng H, Liu C, Wu H, Huang Y, Shao Y. Early Pro-Inflammatory Signal and T-Cell Activation Associate With Vaccine-Induced Anti-Vaccinia Protective Neutralizing Antibodies. Front Immunol 2021;12:737487. [PMID: 34707608 DOI: 10.3389/fimmu.2021.737487] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Shah NJ, Aloysius MM, Sharma NR, Pallav K. Advances in treatment and prevention of hepatitis B. WJGPT 2021;12:56-78. [DOI: 10.4292/wjg.v12.i4.56] [Reference Citation Analysis]
19 Shah NJ, Aloysius MM, Sharma NR, Pallav K. Advances in treatment and prevention of hepatitis B. World J Gastrointest Pharmacol Ther 2021; 12(4): 56-78 [PMID: 34316384 DOI: 10.4292/wjgpt.v12.i4.56] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Franza L, Cianci R. Pollution, Inflammation, and Vaccines: A Complex Crosstalk. Int J Environ Res Public Health 2021;18:6330. [PMID: 34208042 DOI: 10.3390/ijerph18126330] [Reference Citation Analysis]
21 di Iulio J, Bartha I, Spreafico R, Virgin HW, Telenti A. Transfer transcriptomic signatures for infectious diseases. Proc Natl Acad Sci U S A 2021;118:e2022486118. [PMID: 34031243 DOI: 10.1073/pnas.2022486118] [Reference Citation Analysis]
22 Tomic A, Pollard AJ, Davis MM. Systems Immunology: Revealing Influenza Immunological Imprint. Viruses 2021;13:948. [PMID: 34065617 DOI: 10.3390/v13050948] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Lynn DJ, Benson SC, Lynn MA, Pulendran B. Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms. Nat Rev Immunol 2021. [PMID: 34002068 DOI: 10.1038/s41577-021-00554-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 34] [Article Influence: 1.0] [Reference Citation Analysis]
24 Bosco N, Noti M. The aging gut microbiome and its impact on host immunity. Genes Immun 2021. [PMID: 33875817 DOI: 10.1038/s41435-021-00126-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
25 Brophy-Williams S, Fidanza M, Marchant A, Way S, Kollmann TR. One vaccine for life: Lessons from immune ontogeny. J Paediatr Child Health 2021;57:782-5. [PMID: 33860973 DOI: 10.1111/jpc.15511] [Reference Citation Analysis]
26 Nascimento Júnior JAC, Santos AM, Cavalcante RCM, Quintans-Júnior LJ, Walker CIB, Borges LP, Frank LA, Serafini MR. Mapping the technological landscape of SARS, MERS, and SARS-CoV-2 vaccines. Drug Dev Ind Pharm 2021;47:673-84. [PMID: 33826439 DOI: 10.1080/03639045.2021.1908343] [Reference Citation Analysis]
27 Schijns V, Majhen D, van der Ley P, Thakur A, Summerfield A, Berisio R, Nativi C, Fernández-Tejada A, Alvarez-Dominguez C, Gizurarson S, Zamyatina A, Molinaro A, Rosano C, Jakopin Ž, Gursel I, McClean S. Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation. Pharmaceutics 2021;13:501. [PMID: 33917629 DOI: 10.3390/pharmaceutics13040501] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Schneider JL, Rowe JH, Garcia-de-Alba C, Kim CF, Sharpe AH, Haigis MC. The aging lung: Physiology, disease, and immunity. Cell 2021;184:1990-2019. [PMID: 33811810 DOI: 10.1016/j.cell.2021.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
29 Stanisic DI, McCall MBB. Correlates of malaria vaccine efficacy. Expert Rev Vaccines 2021;20:143-61. [PMID: 33499692 DOI: 10.1080/14760584.2021.1882309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
30 Koff WC, Schenkelberg T, Williams T, Baric RS, McDermott A, Cameron CM, Cameron MJ, Friemann MB, Neumann G, Kawaoka Y, Kelvin AA, Ross TM, Schultz-Cherry S, Mastro TD, Priddy FH, Moore KA, Ostrowsky JT, Osterholm MT, Goudsmit J. Development and deployment of COVID-19 vaccines for those most vulnerable. Sci Transl Med 2021;13:eabd1525. [PMID: 33536277 DOI: 10.1126/scitranslmed.abd1525] [Cited by in Crossref: 13] [Cited by in F6Publishing: 33] [Article Influence: 13.0] [Reference Citation Analysis]
31 Alexander JL, Moran GW, Gaya DR, Raine T, Hart A, Kennedy NA, Lindsay JO, MacDonald J, Segal JP, Sebastian S, Selinger CP, Parkes M, Smith PJ, Dhar A, Subramanian S, Arasaradnam R, Lamb CA, Ahmad T, Lees CW, Dobson L, Wakeman R, Iqbal TH, Arnott I, Powell N; Inflammatory Bowel Disease section of the British Society of Gastroenterology and the the Inflammatory Bowel Disease Clinical Research Group. SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement. Lancet Gastroenterol Hepatol 2021;6:218-24. [PMID: 33508241 DOI: 10.1016/S2468-1253(21)00024-8] [Cited by in Crossref: 65] [Cited by in F6Publishing: 37] [Article Influence: 65.0] [Reference Citation Analysis]
32 Shannon CP, Blimkie TM, Ben-Othman R, Gladish N, Amenyogbe N, Drissler S, Edgar RD, Chan Q, Krajden M, Foster LJ, Kobor MS, Mohn WW, Brinkman RR, Le Cao KA, Scheuermann RH, Tebbutt SJ, Hancock REW, Koff WC, Kollmann TR, Sadarangani M, Lee AH. Multi-Omic Data Integration Allows Baseline Immune Signatures to Predict Hepatitis B Vaccine Response in a Small Cohort. Front Immunol 2020;11:578801. [PMID: 33329547 DOI: 10.3389/fimmu.2020.578801] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
33 Segal JP, Mak JWY, Mullish BH, Alexander JL, Ng SC, Marchesi JR. The gut microbiome: an under-recognised contributor to the COVID-19 pandemic? Therap Adv Gastroenterol 2020;13:1756284820974914. [PMID: 33281941 DOI: 10.1177/1756284820974914] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
34 Soni D, Van Haren SD, Idoko OT, Evans JT, Diray-Arce J, Dowling DJ, Levy O. Towards Precision Vaccines: Lessons From the Second International Precision Vaccines Conference. Front Immunol 2020;11:590373. [PMID: 33178222 DOI: 10.3389/fimmu.2020.590373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
35 Pereira B, Xu XN, Akbar AN. Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly. Front Immunol 2020;11:583019. [PMID: 33178213 DOI: 10.3389/fimmu.2020.583019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 39] [Article Influence: 9.0] [Reference Citation Analysis]
36 Calina D, Sarkar C, Arsene AL, Salehi B, Docea AO, Mondal M, Islam MT, Zali A, Sharifi-Rad J. Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development. Immunol Res 2020;68:315-24. [PMID: 33006053 DOI: 10.1007/s12026-020-09154-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
37 Malik YS, Ansari MI, Ganesh B, Sircar S, Bhat S, Pande T, Vinodhkumar OR, Kumar P, Iqbal Yatoo M, Tiwari R, Touil N, Patel SK, Pathak M, Sharun K, Dhama K. BCG vaccine: a hope to control COVID-19 pandemic amid crisis. Hum Vaccin Immunother 2020;16:2954-62. [PMID: 32991235 DOI: 10.1080/21645515.2020.1818522] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
38 Jain A, Ramasamy K. Potential 'significance' of monoclonal gammopathy of 'undetermined significance' during COVID-19 pandemic. Blood Cells Mol Dis 2020;85:102481. [PMID: 32745940 DOI: 10.1016/j.bcmd.2020.102481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Camponovo F, Campo JJ, Le TQ, Oberai A, Hung C, Pablo JV, Teng AA, Liang X, Sim BKL, Jongo S, Abdulla S, Tanner M, Hoffman SL, Daubenberger C, Penny MA. Proteome-wide analysis of a malaria vaccine study reveals personalized humoral immune profiles in Tanzanian adults. Elife 2020;9:e53080. [PMID: 32662772 DOI: 10.7554/eLife.53080] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]